ViraCyte's Grant - II Round

ViraCyte raised a round of funding on August 21, 2017. Investors include Cancer Prevention and Research Institute of Texas.

ViraCyte is a clinical-stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe life-threatening infections. The company provides products that restore…

Articles about ViraCyte's Grant - II Round: